Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

Trial Profile

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin
  • Indications Ischaemic heart disorders; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Aug 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top